Market Place
Sourcing Support
FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea
Biologics, or complex drugs that are derived from living organisms, have revolutionized treatment of
New Drugs Approvals by FDA and EMA: 2020 Recap
The year
2020 was an eventful year for the pharmaceutical industry, with several
companies across
New Drug Approvals by FDA & EMA (Mid-2020 Recap)
In case you thought Covid-19 had slowed down US Food and Drug Administration’s New Drug Approv
